Colgate-Palmolive (NYSE:CL) Shares Acquired by Blair William & Co. IL

Blair William & Co. IL lifted its holdings in shares of Colgate-Palmolive (NYSE:CL) by 0.2% during the 1st quarter, Holdings Channel.com reports. The fund owned 277,762 shares of the company’s stock after buying an additional 545 shares during the period. Blair William & Co. IL’s holdings in Colgate-Palmolive were worth $25,012,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in CL. Norges Bank purchased a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $731,843,000. Price T Rowe Associates Inc. MD increased its position in Colgate-Palmolive by 16.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 32,133,218 shares of the company’s stock worth $2,561,340,000 after buying an additional 4,625,472 shares during the period. Magellan Asset Management Ltd lifted its stake in Colgate-Palmolive by 4,162.6% in the fourth quarter. Magellan Asset Management Ltd now owns 2,016,290 shares of the company’s stock valued at $160,718,000 after buying an additional 1,968,988 shares during the last quarter. Confluence Investment Management LLC purchased a new position in shares of Colgate-Palmolive during the first quarter worth approximately $130,622,000. Finally, Allspring Global Investments Holdings LLC grew its position in shares of Colgate-Palmolive by 461.5% during the first quarter. Allspring Global Investments Holdings LLC now owns 1,036,215 shares of the company’s stock worth $93,311,000 after acquiring an additional 851,671 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently weighed in on CL. Stifel Nicolaus increased their price target on shares of Colgate-Palmolive from $94.00 to $95.00 and gave the stock a “buy” rating in a research note on Monday, April 29th. Barclays increased their target price on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the stock an “equal weight” rating in a research note on Friday. Wells Fargo & Company upped their price target on Colgate-Palmolive from $92.00 to $97.00 and gave the stock an “equal weight” rating in a research note on Wednesday, July 10th. Morgan Stanley lifted their price objective on shares of Colgate-Palmolive from $101.00 to $103.00 and gave the company an “overweight” rating in a research report on Tuesday, May 28th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on shares of Colgate-Palmolive from $98.00 to $104.00 and gave the stock a “buy” rating in a research report on Wednesday. Three analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $96.94.

Colgate-Palmolive Price Performance

Shares of NYSE:CL traded down $0.42 during trading on Friday, hitting $98.09. 4,228,214 shares of the stock were exchanged, compared to its average volume of 4,384,501. The company has a market cap of $80.48 billion, a PE ratio of 31.04, a P/E/G ratio of 3.66 and a beta of 0.39. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 13.21. The company has a fifty day moving average price of $95.47 and a two-hundred day moving average price of $89.34. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $99.63.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.82 by $0.04. The firm had revenue of $5.07 billion during the quarter, compared to analysts’ expectations of $4.96 billion. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. Colgate-Palmolive’s revenue was up 6.2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.73 earnings per share. On average, analysts forecast that Colgate-Palmolive will post 3.54 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be paid a $0.50 dividend. The ex-dividend date is Friday, July 19th. This represents a $2.00 dividend on an annualized basis and a yield of 2.04%. Colgate-Palmolive’s payout ratio is 63.29%.

Insiders Place Their Bets

In related news, insider John W. Kooyman sold 3,497 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total transaction of $326,864.59. Following the completion of the transaction, the insider now directly owns 3,181 shares in the company, valued at approximately $297,328.07. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of the firm’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the sale, the insider now directly owns 13,924 shares of the company’s stock, valued at approximately $1,309,691.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider John W. Kooyman sold 3,497 shares of Colgate-Palmolive stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total transaction of $326,864.59. Following the sale, the insider now owns 3,181 shares of the company’s stock, valued at $297,328.07. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.